Literature DB >> 2493377

Stable human immunodeficiency virus encephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial prophylaxis.

U A Hunziker1, D Nadal, J B Jendis, Z Tomasik, J C Wetzel, J Schüpbach, R A Seger.   

Abstract

Two infants with human immunodeficiency virus (HIV) infection, encephalopathy, intrathecal anti-HIV IgG antibody production and (in one case) the presence of HIV antigen received monthly doses of intravenous gammaglobulin (IVGG) and daily antimicrobial prophylaxis starting at the ages of 6 and 9 months respectively. The follow-up over 15 and 12 months revealed a favourable course with remarkable improvement in visuo-spatial functions, receptive language, play behaviour and fine motor skills, as well as in muscle tone, pyramidal tract signs and vigilance in case 1, and near normalization in case 2. Viability of HIV in peripheral blood mononuclear cells, antigen in serum and cellular immunodeficiency, however, all remained unchanged. We suggest that neurological complications of encephalopathy in paediatric acquired immunodeficiency syndrome may have a slower progression when IVGG treatment plus antimicrobial prophylaxis is started early.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493377     DOI: 10.1007/bf00595901

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  Life table analysis of children with acquired immunodeficiency syndrome.

Authors:  R Lampert; J Milberg; R O'Donnell; A Kristal; P Thomas
Journal:  Pediatr Infect Dis       Date:  1986 May-Jun

2.  Pediatric acquired immunodeficiency syndrome. Neurologic syndromes.

Authors:  A L Belman; G Diamond; D Dickson; D Horoupian; J Llena; G Lantos; A Rubinstein
Journal:  Am J Dis Child       Date:  1988-01

3.  [Body measurements, growth velocity and bone age of healthy children up to 12 years of age (longitudinal growth study Zurich) (author's trnasl)].

Authors:  A Prader; H Budliger
Journal:  Helv Paediatr Acta       Date:  1977

4.  Neurological complications in infants and children with acquired immune deficiency syndrome.

Authors:  A L Belman; M H Ultmann; D Horoupian; B Novick; A J Spiro; A Rubinstein; D Kurtzberg; B Cone-Wesson
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

5.  Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. A new dysmorphic syndrome associated with intrauterine HTLV-III infection.

Authors:  R W Marion; A A Wiznia; G Hutcheon; A Rubinstein
Journal:  Am J Dis Child       Date:  1986-07

6.  Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation.

Authors:  S Blanche; F Le Deist; A Fischer; F Veber; M Debre; S Chamaret; L Montagnier; C Griscelli
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

7.  Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.

Authors:  M Robert-Guroff; J M Oleske; E M Connor; L G Epstein; A B Minnefor; R C Gallo
Journal:  Pediatr Res       Date:  1987-06       Impact factor: 3.756

8.  Developmental abnormalities in infants and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex.

Authors:  M H Ultmann; A L Belman; H A Ruff; B E Novick; B Cone-Wesson; H J Cohen; A Rubinstein
Journal:  Dev Med Child Neurol       Date:  1985-10       Impact factor: 5.449

9.  Restoration of suppressor T-cell functions in children with AIDS following intravenous gamma globulin treatment.

Authors:  A Gupta; B E Novick; A Rubinstein
Journal:  Am J Dis Child       Date:  1986-02

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  2 in total

Review 1.  Does intravenous immune globulin have a role in HIV-infected patients?

Authors:  P L Yap
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

2.  Intravenous immunoglobulin in HIV-I infected haemophilic patients.

Authors:  N Wagner; R Bialek; H Radinger; H H Brackmann; M Becker
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.